M. Haase

Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates.

M. Haase, 2002, Blood.

Factor VIII products and inhibitor development: concepts for revision of European regulatory guidelines

R. Seitz, D. Mentzer, B. Keller-Stanislawski, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Guidelines on stability evaluation of vaccines.

T. Schofield, I. Susanti, M. Pfleiderer, 2009, Biologicals : journal of the International Association of Biological Standardization.

Stability testing on vaccines--results of activities of the International Conference on Harmonization (ICH) of technical requirements for registration of pharmaceuticals for human use.

M Haase, M. Haase, 1994, Biologicals : journal of the International Association of Biological Standardization.

Licensing of Pneumococcal Conjugate Vaccines for Children and Adults: Regulatory Perspective from the European Medicines Agency and the U.S. Food and Drug Administration

M. Gruber, D. Pratt, M. Haase, 2008 .

[Human diploid cell (HDC) rabies vaccine immunoprophylaxis in persons at risk (author's transl)].

W. Schneider, M. Haase, 1978, Deutsche Medizinische Wochenschrift.